Incidence of lymphoid markers in acute myeloid leukemia: alkaline phosphatase-antialkaline phosphatase versus immunofluorescence

R Longo, A Vecchi, C Messora, S Sacchi - Acta haematologica, 1991 - karger.com
The aim of the present study was to compare the immunofluorescence technique (IF) with
the immunoenzymatic (IE) alkaline phosphatase-antialkaline phosphatase method for the …

[HTML][HTML] A case of acute myeloid leukemia with inv (16)(p13. 1q22); CBFB-MYH11 presenting with faggot cells

JA Kim, WY Shin, J Kim, HI Bang, SY Yoon… - Annals of Laboratory …, 2021 - ncbi.nlm.nih.gov
Dear Editor, Unlike in other acute myeloid leukemias (AMLs), in acute promyelocytic
leukemia (APL), bleeding is the most common cause of early death. Thus, prompt treatment …

N-CAM (CD56) expression by CD34+ malignant myeloblasts has implications for minimal residual disease detection in acute myeloid leukemia.

E Coustan-Smith, FG Behm, CA Hurwitz, GK Rivera… - Leukemia, 1993 - europepmc.org
The molecules detected by CD34 and CD56 monoclonal antibodies are simultaneously
expressed in approximately 20% of childhood acute myeloid leukemia (AML) cases, and this …

Diagnostic value of CD117 in differential diagnosis of acute leukemias

A Ahmadi, AA Poorfathollah, M Aghaiipour, M Rezaei… - Tumor biology, 2014 - Springer
Abstract C-kit receptor (CD117) and its ligand, stem cell factor, play a key role in normal
hematopoiesis. It has been demonstrated that its expression extremely increases in …

Correlation between CD34 expression and chromosomal abnormalities but not clinical outcome in acute myeloid leukemia

C Fruchart, B Lenormand, C Bastard… - American journal of …, 1996 - Wiley Online Library
The hemopoletic stem cell marker CD34 has been reported to be a useful predictor of
treatment outcome in acute myeloid leukemia (AML). Previous data suggested that CD34 …

CD7+ and CD56+ Myeloid/Natural Killer Cell Precursor Acute Leukemia: A Distinct Hematolymphoid Disease Entity

R Suzuki, K Yamamoto, M Seto… - Blood, The Journal …, 1997 - ashpublications.org
The disease spectrum of natural killer (NK) cell leukemias and lymphomas has recently
been expanding with the continuing evolution in diagnostic concepts. We describe here …

[HTML][HTML] T-cell acute lymphoblastic leukemia with co-expression of CD56, CD34, CD117 and CD33: A case with poor prognosis

R Eren, C Aslan, O Yokuş… - Molecular and …, 2016 - spandidos-publications.com
T-cell acute lymphoblastic leukemia (ALL) is an aggressive hematological malignancy,
accounting for~ 25% of all adult cases of ALL. We herein report a case of T-cell ALL …

[PDF][PDF] Isolated asymptomatic severe neutropenia as the presentation of myeloid/natural killer cell acute leukemia

M Rubio-Batllés, AC de La Mata, M Romero… - …, 2000 - haematologica.org
3. Droll A, Dougherty ST, Chiu RK, et al. Adhesive interactions between alternatively spliced
CD44 isoforms. J Biol Chem 1995; 270: 11567-73. 4. Rafi A, Nagarkatti M, Nagarkatti PS …

[HTML][HTML] CD47 expression in acute myeloid leukemia varies according to genotype

A Marra, AU Akarca, G Martino, A Ramsay… - …, 2023 - ncbi.nlm.nih.gov
CD47 is a “don't eat me” signal to phagocytes, that is overexpressed in solid and blood
tumors and represents a key mechanism of immune evasion in cancer. 1 Engagement of …

Acute myeloid leukaemia (FAB AML‐M4Eo) with cryptic insertion of cbfb resulting in cbfb‐Myh11 fusion

N Douet‐Guilbert, A Chauveau… - Hematological …, 2017 - Wiley Online Library
Abstract Inv (16)(p13q22) and t (16; 16)(p13; q22) are cytogenetic hallmarks of acute
myelomonoblastic leukaemia, most of them associated with abnormal bone marrow …